97622009 - MBL

Information

  • Trademark
  • 97622009
  • Serial Number
    97622009
  • Filing Date
    October 06, 2022
    3 years ago
  • Transaction Date
    July 02, 2025
    3 months ago
  • Status Date
    July 01, 2025
    3 months ago
  • Published for Opposition Date
    May 06, 2025
    5 months ago
  • Location Date
    July 01, 2025
    3 months ago
  • Status Code
    688
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    GOODWIN, KATRINA
  • Attorney Docket Number
    1217-2206716
    Attorney Name
    JAMES J. BOSCO, JR.
    Law Office Assigned Location Code
    L50
  • Owners
Mark Drawing Code
5
Mark Identification
MBL
Case File Statements
  • DM0000: The mark consists of MBL in a stylized blue font with the leg of the "L" curving upward.
  • GS0051: Chemical reagents for medical purposes in the fields of cancer, cardiology, autoimmunity and immunological disorders, respiratory diseases, apoptosis, signal transduction, DNA, proteomics and genomics; Reagents for use in medical genetic testing; Immunoassay reagents for medical use; Diagnostic biomarker reagents for medical purposes; Companion diagnostics, namely, medical diagnostic reagents that assist in predicting the effects of a drug, the presence or absence of side effects, and the choice of patients to administer
  • PM0001: MEDICAL AND BIOLOGICAL LABORATORIES
  • CC0000: The color(s) blue is/are claimed as a feature of the mark.
  • GS0421: Testing, analysis and evaluation for approval of goods and services of others to ensure compliance with industry standards; Research and development services in the field of pharmaceutical products; Research and development services in the field of antibodies; Laboratory research services in the field of pharmaceuticals using experimental animals; Cell culture services for scientific and research purposes, for others; Stem cell research services; Consulting services in the field of biotechnology; Laboratory research services relating to pharmaceuticals, in vitro diagnostics, treatment or diagnostics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical laboratory services; Medical research services in the field of cancer; Pharmaceutical drug development support services, namely, pharmaceutical research and development; Scientific and technological services, namely, analyzing preclinical oncology efficacy in the field of medical treatment
Case File Event Statements
  • 10/10/2022 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 10/23/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/20/2023 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/4/2023 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/4/2023 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/4/2023 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 11/6/2023 - a year ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/6/2023 - a year ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/6/2023 - a year ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/12/2024 - a year ago
    10 - FINAL REFUSAL WRITTEN Type: CNFR
  • 1/12/2024 - a year ago
    11 - FINAL REFUSAL E-MAILED Type: GNFR
  • 1/12/2024 - a year ago
    12 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 4/12/2024 - a year ago
    15 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 2/20/2024 - a year ago
    13 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/12/2024 - a year ago
    14 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 7/12/2024 - a year ago
    19 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 7/12/2024 - a year ago
    16 - EXPARTE APPEAL RECEIVED AT TTAB Type: EXAF
  • 7/12/2024 - a year ago
    17 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT
  • 7/12/2024 - a year ago
    18 - EX PARTE APPEAL-INSTITUTED Type: EXPI
  • 9/24/2024 - a year ago
    21 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 9/24/2024 - a year ago
    22 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 9/24/2024 - a year ago
    20 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 4/7/2025 - 6 months ago
    23 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/7/2025 - 6 months ago
    24 - EXPARTE APPEAL TERMINATED Type: EXPT
  • 4/30/2025 - 5 months ago
    25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/6/2025 - 5 months ago
    26 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/6/2025 - 5 months ago
    27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/1/2025 - 3 months ago
    28 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM